MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.
MedAvail has raised $16.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2023.
MedAvail's investors include Adage Capital Management, Redmile Group, Ally Bridge Group, Deerfield, Lewis & Clark Ventures.
MedAvail is headquartered in Mississauga, Canada.
MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.
MedAvail is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MedAvail — Funding & Investors." VCBacked, March 14, 2023, https://www.vcbacked.co/company/medavail. Accessed August 15, 2026.
VCBacked. (2023). MedAvail — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/medavail
{{cite web |title=MedAvail — Funding & Investors |url=https://www.vcbacked.co/company/medavail |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated